KalVista Pharmaceuticals, Inc. SEC Filings

Filed On	Filing
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
11 Aug 2026	SCHEDULE 13G
22 Jun 2026	15-12G
16 Jun 2026	EFFECT
11 Jun 2026	S-8 POS
11 Jun 2026	Form 4: Stuart Nancy, Director Disposed of 74,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2026	Form 4: Pereira Brian Jg, Director Disposed of 91,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2026	Form 4: Fairey William, Director Disposed of 57,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2026	Form 4: Audhya Paul K., CHIEF MEDICAL OFFICER Returned 150,260 shares to the issuer · Disposed of 125,800 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 202,500 Restricted Stock Unit (Disposition to Issuer)
11 Jun 2026	S-8 POS
11 Jun 2026	Form 4: Sensenig Bethany, Director Disposed of 45,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2026	S-8 POS
11 Jun 2026	S-8 POS
11 Jun 2026	Form 4: Treanor Patrick, Director Disposed of 67,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2026	Form 4: Sweeny Nicole, Chief Commercial Officer Returned 59,291 shares to the issuer · Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 202,500 Restricted Stock Unit (Disposition to Issuer)
11 Jun 2026	S-8 POS
11 Jun 2026	Form 4: Arif Bilal, Chief Operations Officer Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 49,000 Restricted Stock Unit (Disposition to Issuer)
11 Jun 2026	Form 4: Reid Laurence, Director Disposed of 17,000 Stock Option (Right to Buy) (Disposition to Issuer)

Comments